CEO & Head of Research at 5i Research Inc.
Member since: Feb '03 · 2294 Opinions
(A Top Pick Jan 23/20, Up 14%) It's been a crazy ride, bouncing up and down sharply since its IPO then during Covid. It delivered a stunning second quarter in the middle of the pandemic, growing 70% which stunned the markets. They shifted business online. They put in a U.S. IPO which investors gobbled up and are calling it the next Shopify. Sitting on a lot of cash, they just did a nice acquisition in the U.S. to bulk up their revenue. Management knows what they're doing.
He didn't like it for a while, but now more than before. The telehealth space is getting crowded and they've had issues with CMS code. It's a good American company, though doesn't receive much attention here. VMS is merely okay. He prefers other names like Knight Therapeutics. It's a decent, second-tier company.